Log In
Print
BCIQ
Print
Print this Print this
 

Elidel, pimecrolimus

Also known as: ASM 981

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionNon-steroidal pimecrolimus (ascomycin derivative) 1% cream
Molecular Target FK506 binding protein (macrophilin-12)
Mechanism of ActionCalcineurin inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDermatitis
Indication DetailsModerate atopic eczema; Treat atopic dermatitis (eczema); Treat mild to moderate atopic dermatitis (eczema)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today